[HTML][HTML] Contact isolation versus standard precautions to decrease acquisition of extended-spectrum β-lactamase-producing Enterobacterales in non-critical care …

F Maechler, F Schwab, S Hansen… - The Lancet infectious …, 2020 - thelancet.com
Background The effectiveness of contact isolation for decreasing the spread of extended-
spectrum β-lactamase-producing Enterobacterales (ESBL-E) has been questioned. The aim …

[PDF][PDF] Prevalence of extended Spectrum Beta-lactamase producing Enterobacteriaceae: a cross sectional study at Adama hospital, Adama, Ethiopia

G Mulisa, L Selassie, G Jarso, T Shiferew… - J Emerg Infect …, 2016 - researchgate.net
Background: The beta-lactam groups of antibiotics are the largest group of antibacterial
agents used in clinical practice and they are frequently prescribed. The wide use of these …

Risk factors for bloodstream infection caused by extended-spectrum β-lactamase–producing Escherichia coli and Klebsiella pneumoniae: a focus on antimicrobials …

T Chopra, D Marchaim, PC Johnson, IK Chalana… - American journal of …, 2015 - Elsevier
Background Extended-spectrum β-lactamase (ESBL)–producing pathogens represent
increasing challenges to physicians because of rising prevalence, high mortality, and …

Trends in production of extended-spectrum β-lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey

F Luzzaro, M Mezzatesta, C Mugnaioli… - Journal of clinical …, 2006 - Am Soc Microbiol
Results of a 2003 survey carried out in Italy to evaluate the prevalence of extended-
spectrum β-lactamase (ESBL)-producing enterobacteria are presented. Eleven Italian …

[HTML][HTML] Epidemiology and acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a septic orthopedic ward

A Agostinho, G Renzi, T Haustein, G Jourdan… - SpringerPlus, 2013 - Springer
Wards cohorting infected orthopaedic patients may be particularly prone to transmitting
extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E). We analyze …

[HTML][HTML] Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study

G Peralta, M Lamelo, P Álvarez-García… - BMC infectious …, 2012 - Springer
Background The objective of this study is to analyze the factors that are associated with the
adequacy of empirical antibiotic therapy and its impact in mortality in a large cohort of …

[HTML][HTML] ESBLs: a clear and present danger?

RHP Dhillon, J Clark - Critical care research and practice, 2012 - hindawi.com
Extended spectrum β-lactamases (ESBLs) are enzymes produced by a variety of Gram
negative bacteria which confer an increased resistance to commonly used antibiotics. They …

[HTML][HTML] Mortality and its predictors among hospitalized patients with infections due to extended spectrum beta-lactamase (ESBL) Enterobacteriaceae in Malaysia: a …

U Abubakar, B Tangiisuran, MH Elnaem… - Future Journal of …, 2022 - Springer
Background Extended spectrum beta-lactamase (ESBL) pathogens are associated with
morbidity and mortality. There is a paucity of data describing the treatments and outcomes of …

Association of high mortality with extended–spectrum β-lactamase (ESBL) positive cultures in community acquired infections

S Ray, D Anand, S Purwar, A Samanta, KV Upadhye… - Journal of critical …, 2018 - Elsevier
Purpose Infections due to multidrug resistant organisms have become a serious health
concern worldwide. The present study was conducted to investigate the spectrum of …

Beta-lactam/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae …

MM Sfeir, G Askin, P Christos - International journal of antimicrobial agents, 2018 - Elsevier
Background Infections due to extended-spectrum beta-lactamase (ESBL)-producing
Enterobacteriaceae pose a major public health threat due to poor outcomes and high …